AAAAAA

   
Results: 1-12 |
Results: 12
Non-invasive antidromic neurostimulation: A simple effective method for improving bladder storage
Authors: Walsh, IK Thompson, T Loughridge, WGG Johnston, SR Keane, PF Stone, AR
Citation: Ik. Walsh et al., Non-invasive antidromic neurostimulation: A simple effective method for improving bladder storage, NEUROUROL U, 20(1), 2001, pp. 73-81
Non-invasive antidromic neurostimulation: A simple effective method for improving bladder storage - Reply
Authors: Walsh, IK Keane, PF Stone, AR
Citation: Ik. Walsh et al., Non-invasive antidromic neurostimulation: A simple effective method for improving bladder storage - Reply, NEUROUROL U, 20(1), 2001, pp. 83-84
The BTA stat test: A tumor marker for the detection of upper tract transitional cell carcinoma
Authors: Walsh, IK Keane, PF Ishak, LM Flessland, KA
Citation: Ik. Walsh et al., The BTA stat test: A tumor marker for the detection of upper tract transitional cell carcinoma, UROLOGY, 58(4), 2001, pp. 532-535
The effect of antisense Bcl-2 oligonucleotides on Bcl-2 protein expressionand apoptosis in human bladder transitional cell carcinoma
Authors: Duggan, BJ Maxwell, P Kelly, JD Canning, P Anderson, NH Keane, PF Johnston, SR Williamson, KE
Citation: Bj. Duggan et al., The effect of antisense Bcl-2 oligonucleotides on Bcl-2 protein expressionand apoptosis in human bladder transitional cell carcinoma, J UROL, 166(3), 2001, pp. 1098-1105
Molecular targets for the therapeutic manipulation of apoptosis in bladdercancer
Authors: Duggan, BJ Kelly, JD Keane, PF Johnston, SR Williamson, KE
Citation: Bj. Duggan et al., Molecular targets for the therapeutic manipulation of apoptosis in bladdercancer, J UROL, 165(3), 2001, pp. 946-954
Bcl-2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapy
Authors: Duggan, B Kelly, J Keane, PF Williamson, K Johnston, SR
Citation: B. Duggan et al., Bcl-2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapy, BJU INT, 86(6), 2000, pp. 757-757
Bcl-2 proto-oncogene expression in low- and high-grade prostatic intraepithelial neoplasia
Authors: Duggan, BJ Maxwell, P Kelly, JD Williamson, KE Keane, PF Johnston, SR
Citation: Bj. Duggan et al., Bcl-2 proto-oncogene expression in low- and high-grade prostatic intraepithelial neoplasia, BJU INT, 86(3), 2000, pp. 406-406
Induction of apoptosis by mitomycin-C in an ex vivo model of bladder cancer
Authors: Kelly, JD Williamson, KE Weir, HP McManus, DT Hamilton, PW Keane, PF Johnston, SR
Citation: Jd. Kelly et al., Induction of apoptosis by mitomycin-C in an ex vivo model of bladder cancer, BJU INT, 85(7), 2000, pp. 911-917
Contractile properties of human renal cell carcinoma recruited arteries and their response to nicotinamide
Authors: Ruddock, MW Burns, DM McKeown, SR Murphy, L WAlsh, IK Keane, PF Hirst, DG
Citation: Mw. Ruddock et al., Contractile properties of human renal cell carcinoma recruited arteries and their response to nicotinamide, RADIOTH ONC, 54(2), 2000, pp. 179-184
Urodynamic variables cannot be used to classify the severity of detrusor instability
Authors: Walsh, IK Keane, PF Loughridge, WGG Johnstone, SR
Citation: Ik. Walsh et al., Urodynamic variables cannot be used to classify the severity of detrusor instability, BJU INT, 83(3), 1999, pp. 362-363
Apoptosis and its clinical significance for bladder cancer therapy
Authors: Kelly, JD Williamson, KE Irvine, AE Hamilton, PW Weir, HP Anderson, NH Keane, PF Johnston, SR
Citation: Jd. Kelly et al., Apoptosis and its clinical significance for bladder cancer therapy, BJU INT, 83(1), 1999, pp. 1-10
Transcutaneous sacral neurostimulation for irritative voiding dysfunction
Authors: Walsh, IK Johnston, RS Keane, PF
Citation: Ik. Walsh et al., Transcutaneous sacral neurostimulation for irritative voiding dysfunction, EUR UROL, 35(3), 1999, pp. 192-196
Risultati: 1-12 |